Metallo-β-lactamase Producing Bacteria in Korean Hospitals
Author Information
Author(s): Lee Kyungwon, Lee Wee Gyo, Uh Young, Ha Gyoung Yim, Cho Jihyun, Chong Yunsop
Primary Institution: Yonsei University College of Medicine
Hypothesis
What is the occurrence of acquired metallo-β-lactamase (MBL)–producing bacteria in Korean hospitals?
Conclusion
More than 10% of imipenem-nonsusceptible isolates of Pseudomonas spp. and Acinetobacter spp. were found to be MBL producers, indicating a significant prevalence in Korean hospitals.
Supporting Evidence
- 44 out of 387 Pseudomonas spp. and 38 out of 267 Acinetobacter spp. infections produced MBL.
- MBL-producing isolates were detected in 60.7% of the hospitals surveyed.
- VIM-2 was the only type of acquired MBL identified initially in Korea.
Takeaway
In Korean hospitals, some bacteria that are resistant to a strong antibiotic called imipenem are making a special enzyme that makes them even harder to treat.
Methodology
Isolates were collected from 28 hospitals, and MBL production was screened using specific tests, including PCR for gene detection.
Limitations
The study may not represent all hospitals in Korea as it only included 28 hospitals and relied on the collection of imipenem-nonsusceptible isolates.
Participant Demographics
Isolates were mainly from inpatients and intensive-care unit patients.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website